TITLE:
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

CONDITION:
Breast Neoplasms

INTERVENTION:
LY353381

SUMMARY:

      To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with
      advanced or metastatic breast cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

          1. Locally advanced or metastatic breast cancer

          2. Bi-dimensionally measurable disease

        Exclusion Criteria

        1. Prior hormonal therapy
      
